Aurobindo Pharma Market Cap

Aurobindo Pharma has a market cap or net worth of 680.47 billion as of April 17, 2025. Its market cap has increased by 8.50% in one year.

Market Cap

680.47B

Enterprise Value

696.12B

Revenue

309.22B

Ranking

n/a

PE Ratio

19.59

Stock Price

1,171.60

Market Cap Chart

Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 680.47B, an increase of 6,985.78%. That is a compound annual growth rate of 20.54%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2025	680.47B	-12.21%
Dec 31, 2024	775.08B	22.03%
Dec 29, 2023	635.16B	147.32%
Dec 30, 2022	256.82B	-40.31%
Dec 31, 2021	430.28B	-20.29%
Dec 31, 2020	539.83B	101.66%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,202.44B
Divi's Laboratories	1,497.24B
Cipla	1,223.70B
Mankind Pharma	1,065.11B
Apollo Hospitals Enterprise	1,017.06B
Zydus Lifesciences	836.73B
Alkem Laboratories	592.24B
Fortis Healthcare	501.71B

Market Cap Rankings